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Summary Epidemiological findings indicate that both cryptorchid testis and testicular germ cell cancer may
be a result of high maternal oestrogen levels early in pregnancy. An experiment was conducted with a mouse
strain (129 Sv-S C P) in which the males are susceptible to testicular teratomas to determine if the frequency
of undescended testis and testicular teratoma in male offspring could be increased by administration of ethinyl
oestradiol (EE) to pregnant mice before day 13 of gestation. This point in gestation marks the completion of
the migration of germ cells to the gonadal ridge in mice and other studies with these mice have shown that the
tumours are initiated in this critical time period. EE mixed with corn oil was administered by subcutaneous
injection in doses of 0.02 (n = 76) and 0.2 (n = 102) mg kg- of body weight on gestational days 11 and 12.
These mice were allowed to deliver their offspring and the males were killed at 15 days of age. Since the
tumours are present from birth, this amount of time was allowed to permit the tumours to reach sufficient size
for easy visual identification. Compared to controls (n = 63), who received corn oil alone, the treated mothers
produced offspring who were significantly more likely to have a cryptorchid testis (P = 0.0001) and who had
an increased risk, although not significant, of a testicular teratoma.
Crytorchidism is a known risk factor for human testicular
cancer (Henderson et al., 1979; Schottenfeld et al., 1980;
Depue et al., 1983) and there is evidence that both conditions
may share the common aetiological factor of high maternal
oestrogen levels early in gestation. In animals, testicular
maldescent has been experimentally produced by administer-
ing oestrogen during gestation (Jean, 1973; McLachlan et al.,
1975; Nomura & Kanzaki, 1977; Yasuda et al., 1985). In
humans, an increased frequency of cryptorchidism has been
found in males who were exposed in utero to diethylstilbes-
trol (DES) (Cosgrove et al., 1977; Whitehead & Leiter, 1981).
Recently, it was shown that levels of free oestradiol measured
in serum obtained during the first trimester of pregnancy of
mothers bearing a cryptorchid son were significantly higher
than those of control mothers (Bernstein et al., 1988).
With regard to cancer of the testis (including seminoma
and nonseminoma subtypes), epidemiological studies have
indicated that high maternal oestrogen levels in the first
trimester of pregnancy may increase the subsequent risk of
germ cell tumours in male offspring (Henderson et al., 1979;
Depue et al., 1983). Both exogenous and endogenous sources
of oestrogen have been implicated (Henderson et al., 1983;
Bernstein et al., 1986; Depue et al., 1987). Certain sublines of
the 129J mouse strain have a relatively high spontaneous
incidence of testicular teratomas. Embryonal carcinoma cells
appear to be the stem cells of these tumours and give rise to
the differentiated cell types often observed. As the mouse
becomes older the incidence of the embryonal carcinoma cells
is much lower, due most likely to their differentiation into
normal cells. As is usually the case, all of the embryonal
carcinoma cells eventually disappear and the tumour is be-
nign (Stevens, 1982).
These tumours, which develop from the primordial germ
cells, appear to be present by day 13 of gestation, by which
time migration of germ cells to the gonadal ridge is com-
pleted in the mouse (Chiquone, 1954). At gestational day
12.5 the germ cells are located in the medullary portion of
the genital ridge, but by gestational day 13.5 they are located
within the seminiferous tubules (Stevens, 1966). The primor-
dial germ cells appear to undergo an important period of
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maturation after 12 days of gestation that causes them to be
resistant to teratocarcinogenesis (Stevens, 1982).
Experiments with these mice indicate that both genetic and
environmental factors can affect the incidence of the tes-
ticular teratomas. Factors that suggest an environmental
effect include an increased incidence of teratomas in second
litters versus first ones, and in left versus right testes. The
latter phenomenon may be due to the relocation of the
spermatic artery caused by the introduction of the gene iv
(situs inversus viscerum) into the 129 strain of mice (Stevens,
1982). In addition, changing the location of the genital ridge
during embryonic development, before gestational day 13,
can increase the incidence of teratomas (Stevens & Mac-
kensen, 1961). When genital ridges from mouse fetuses of
12.5 days gestation were grafted on to adult testes of the
same susceptible strain, teratomas developed in 82% of the
grafts; whereas when the grafts were done at day 13.5 of
gestation, teratomas occurred in only 8% of the grafts
(Stevens, 1964).
By altering the hormonal environment of the fetal testis in
this susceptible mouse strain through maternal exposure
before gestational day 13, it may be possible to increase the
incidence of fetal testicular teratomas without removing the
genital ridge from its normal location. Further, it would be
expected that the incidence of cryptorchid testes would be
increased with this type of exposure. The following experi-
ment was designed to test these hypotheses.
Materials and methods
Animals and chemicals
Inbred mice of the 129 Sv-S1 C P strain were provided by Dr
Leroy Stevens from the Jackson Laboratory, Bar Harbor,
Maine, USA. This strain was derived from the mouse sub-
line, called 129/Sv, which has a spontaneous incidence of
testicular teratomas of about 1-2% (Stevens, 1984). The 129
Sv-SI C P strain has an incidence of teratomas of 7% among
animals heterozygous for the S1 gene, which has been shown
to affect the development of primordial germ cells. The C
(pigment) and P (non-pinkeye) genes permit identification
of the genotype of these animals from the phenotype.
Animals with non-pigmented tail-tips are heterozygous for
the S1 gene (S1/+), animals homozygous for the SI gene
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(SI/Si) are white and non-viable, and animals without the SI
gene (+/+) have pigmented tail-tips (Stevens, 1984).
A breeding colony was developed at the University of
Southern California School of Medicine to produce mice for
this study. Seven-week-old females in the experimental
groups were mated to males of the opposite tail tip colour in
order to produce approximately equal numbers of offspring
with non-pigmented and pigmented tail tips (i.e. with and
without the SI gene). Some older, previously untreated fe-
males who had had previous litters were also used in the
experiment. After placement with the male (at a ratio of two
females to one male per cage) the females were checked daily
for the presence of a vaginal plug, and the day of that plug
was considered to be day 0 of the pregnancy. Pregnant
females were kept in individual cages and were fed mouse
breeder pellets and water ad libitum.
Ethinyl oestradiol (EE) was selected for use in this experi-
ment because it has 200 times the biological activity of
oestradiol (E2) and is used in oral contraceptives. Fetal
exposure to this compound may occur if a woman continues
to take oral contraceptives after conception, before realising
that she is pregnant. The doses chosen for this experiment
(0.02 and 0.2 mg kg-' body weight) are equivalent to about
20 and 200 times the amount that a 120 pound (54 kg)
woman would receive daily when taking an oral contracep-
tive containing 50 jig of EE. EE was purchased from Sigma
Chemical Co. (St Louis, MO, USA), dissolved in DMSO,
and diluted with corn oil.
Experimental design
A total of 241 females with vaginal plugs were randomly
allocated to one of three treatment groups: a vehicle control
(n = 63), a low dose EE group (0.02 mg EE per kg body
weight) (n = 76), or a high dose EE group (0.2 mg EE per kg
body weight) (n = 102). Due to the inbred nature of the
strain and also to the effects of EE itself, only 118 or 49% of
these females produced at least one viable male offspring,
with the highest percentage occurring in the control group
(60%) and the lowest in the high dose group (39%). Ten
females in each group who produced at least one viable male
offspring were multiparous at the time of mating. The total
number of male offspring obtained per treatment group was:
control, 107; low dose, 109; and high dose, 115.
Because the transplant evidence suggests that teratoma
induction occurs with greater frequency when the fetal testes
are grafted before 13 days of gestation (Stevens, 1964), EE
was administered before this time. An initial trial in which
EE was administered on days 7-12 resulted in no offspring
from 26 treated mothers. Thus, the exposure period was
changed to days 11 and 12 in order to target the period of
highest susceptibility and minimise the loss of offspring.
The EE was administered by subcutaneous injection using
repeating dispensers which delivered 20yl of the EE/corn oil
solution with each injection. Controls were given 20 ft of
corn oil in each injection. Concentrations of EE needed to
deliver the required doses (0.02 and 0.2 mg kg-') were based
on the mean weight of the animals in each treatment group
obtained within 3 days of each injection.
The females were allowed to deliver their pups and male
offspring were killed at 15 days of age by CO2 asphyxiation.
Since these tumours are present from birth (actually they
have been observed in fetuses as early as 15 days of gesta-
tion: Stevens, 1962), offspring could have been killed earlier,
but the 15 day period of time was selected to allow the
tumours to reach sufficient size for easy visual identification.
The testes were removed and examined for the presence of a
tumour. Cryptorchidism of the testes was also noted and
recorded.
Histology
The testes were fixed in 10% buffered formalin solution and
embedded in paraffin. Five jAm sections were cut and stained
with haematoxylin and eosin. All testes with suspected tu-
mours, based on gross examination, were examined his-
tologically as well as a 10% random sample of the testes
which appeared normal.
Statistics
The risk of crytorchid testis and testicular teratoma in each
treatment group was compared to that ofcontrols using odds
ratio estimates. Mantel-Haenszel odds ratios were computed
(Mantel & Haenszel, 1959) and adjusted for tail-tip pigment
and litter number, as these factors affect the incidence of
spontaneous tumours. Cornfield 95% confidence limits and
adjusted tests of trend across treatment groups were also
calculated (Breslow & Day, 1980).
Results
Cryptorchid testis
In the three experimental groups (i.e. the controls, low dose
EE and high dose EE groups) 331 male offspring were
obtained and a cryptorchid testis was observed in 37. The
undescended testes were almost exclusively on the left side
(only two were found to be on the right side) and 81%
(30/37) occurred among the mice with pigmented tail-tips
(those without the S1 gene).
A strong dose-response effect was found for the occur-
rence of cryptorchid testis as a result of EE exposure, after
statistical adjustment for litter number and tail-tip pigment
(P = 0.0001) (Table I). The adjusted odds ratios were 3.2 in
the low dose group and 8.5 in the high dose group.
Tumour incidence
Testicular teratomas were observed in 24 mice based on the
gross examination. All but one were confirmed to be a
teratoma after histological examination. Nearly 70% (16/23)
of the teratomas were found on the left side. They ranged in
appearance from a barely visible discoloured nodule to larger
tumours measuring up to 0.9 cm in diameter which complete-
ly replaced the testis. No tumours were found in a 10%
random sample of other pairs of testes which were grossly
normal.
After statistically adjusting for the effects of tail-tip pig-
ment and litter number, the risk of teratoma in the EE
treated groups was more than double that for the corn oil
control group (Table I), although these results were not
statistically significant. No dose-response effect was ob-
served (P = 0.37). Statistical adjustment for other factors,
such as the tail-tip pigment of the father or occurrence of a
cryptorchid testis, did not affect these results. The odds ratio
obtained after combining both treatment groups and adjust-
Table I Adjusted odds ratios (OR) for development of a cryptorchid
testis and testicular teratoma as a result of prenatal EE exposure
Treatment
group No./total ORa 95% CI
Cryptorchid testis
Control 4/107 1.0 referent
Low dose EEb 10/109 3.2 (0.9-13.2)
High dose EEC 23/115 8.5 (2.3-28.8)
P value for trend = 0.0001
Teratoma
Control 4/107 1.0 referent
Low dose EEb 11/109 2.6 (0.7-11.0)
High dose EEC 8/115 2.1 (0.5- 9.4)
P value for trend = 0.37
Control 4/107 1.0 referent
Low or high dose EE 19/224 2.4 (0.7- 9.1)
aAdjusted for tail-tip pigment and litter number. bLow dose
EE = 0.02 mg EEperkgondays 11 and 12. CHighdose EE = 0.2 mg EE
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ing for tail-tip pigment (of the offspring) and litter number
was 2.4 (95% CI, 0.7-9.1).
Despite the fact that chance cannot be ruled out as an
explanation for these findings, there was consistency in these
results, with an increased incidence of tumours in the EE
treated groups within the strata of litter number and tail-tip
pigment (Table II). The increases due to EE treatment were
most dramatic in the mice with non-pigmented tail-tips where
the per cent with a teratoma increased from 3.1% among
controls to 11.1% in first litter offspring exposed to either
dose of EE, and from 14.3% to 23.8% in second litter mice.
Joint occurrence ofcryptorchid testis and teratoma
Since the incidence rates for cryptorchid testis and for testic-
ular teratoma are relatively low, the probability that both
would occur in the same animal is quite low, if one assumes
that they are independent events (i.e. that the joint prob-
ability equals the product of the two independent probabil-
ities). There were four animals observed with both outcomes
and all were in the high-dose group. After stratifying on the
offspring's tail-tip pigment and the mother's litter number,
the expected number of animals having both outcomes
among the treated groups was 1.61, assuming these two
outcomes are independent events (Table III). The largest
excess of observed versus expected was among pigmented
tail-tip mice from second litters (3 versus 0.56).
Discussion
The results of this study show that administration of EE to
pregnant mice of the 129 Sv-Sl C P strain before day 13 of
gestation increases the risk of a cryptorchid testis in male
offspring and suggest that the risk of a testicular teratoma
may be increased as well. While the frequency of both out-
comes appears to be related to oestrogen exposure,
differences in the characteristics of animals developing these
outcomes suggest that the aetiologic mechanisms may differ.
The teratomas occurred more frequently in the non-pig-
Table II Percentage of mice with a teratoma by litter number and
tail-tip pigment within treatment group
Litter number Treatment group
and tail-tip Control Low or high dose
pigment % (No./total) % (No./total)
First litter
Pigmented 0.0 (0/48) 1.2 ( 1/ 81)
Non-pigmented 3.1 (1/32) 11.1 (10/ 90)
Total 1.2 (1/80) 6.4 (11/171)
Second or later litter
Pigmented 7.7 (1/13) 9.4 ( 3/ 32)
Non-pigmented 14.3 (2/14) 23.8 ( 5/ 21)
Total 11.1 (3/27) 15.9 ( 8/ 53)
mented tail-tip mice and in second litter mice; and no
dose-response effect was seen. Cryptorchid testes were ob-
served more often in the pigmented mice and appeared
unrelated to litter number; and a strong dose-response effect
was found. Thejoint occurrence of both outcomes was more
frequent than expected, suggesting that both mechanisms
may operate within the same mouse during this critical
exposure period which marks the completion of the migra-
tion of the germ cells to the gonadal ridge.
Testicular descent is thought to be a two stage process
with both stages affected by hormal mechanisms (Hutson &
Donahoe, 1986). Exposure in early pregnancy would affect
the first stage (the initial transabdominal phase) which is
thought to be regulated by mullerian inhibiting substance.
Oestrogens have been shown to inhibit mullerian inhibiting
substance (Newbold et al., 1984; Hutson et al., 1985) and
cause atrophy of the gubernaculum (Wensing, 1973; Grocock
et al., 1988).
The finding that elevated maternal oestrogen levels may
increase the risk of a germ cell tumour is also supported by
consideration of possible biological mechanisms. Regarding
human testicular cancer, a mechanism has been suggested
whereby high oestrogen levels adversely affect germ cells
during their critical period of migration to the gonadal sites,
which occurs during the fourth to sixth weeks of gestation
(Henderson et al., 1983). Later, during puberty and in young
adulthood, it is hypothesised that tumour growth is pro-
moted by exposure to high gonadotropin levels, resulting in
the peak incidence of testis cancer which occurs between 20
and 40 years of age (Henderson et al., 1983).
A possible mechanism for the adverse affect of oestrogen
on germ cells has been demonstrated by Yasuda et al.
(1986a, b) in studies using a non-susceptible mouse strain
(jcl:ICR). In these studies pregnant females were exposed to
the same concentrations of ethinyl oestradiol as used in the
current study (i.e. 0.02 and 0.2 mg kg-' body weight) as well
as 2.0 mg kg-' body weight during days 11-17 of gestation.
The EE was mixed with olive oil and was administered by
oral intubation; the fetuses were examined on gestational day
18.
Electron microscopic examination of fetal gondal tissue
revealed accelerated prespermatogenesis. This was attributed
to the increased ratio of dark to light Sertoli cells which was
found as a result of EE exposure. The dark Sertoli cells
function to increase proliferation of germ cells, while the
light Sertoli cells arrest this process (Wartenburg, 1981). In
normal prenatal development, the light cells eventually pre-
dominate, resulting in the arrest of germ cell proliferation
until puberty. However, if the balance was shifted to the dark
cells as a result of EE exposure, then germ cells may be
induced to proliferate longer at an earlier stage.
Other work by Yasuda et al. (1986b) has indicated that such
levels of EE exposure also result in decreased testosterone
synthesis by Leydig cells, causing a suppression of sperma-
togenesis. Thus prenatal EE exposure appears to have a dual
effect, resulting in accelerated prespermatogenesis due to the
Table III Number and percentage of mice with teratoma and cryptorchid testis, and
observed vs expected number ofboth occurring in same animal, by tail-tip pigment and
litter number within EE treated groups
Tail-tip EE treatedgroupsa
pigmentNubrwt and Percentage Percentage with Number with
litter Total with cryptorchid both outcomes
number n tumour testis observed expected
Pigmented
1st litter 81 1.2 25.9 0 0.25
2nd litter 32 9.4 18.8 3 0.56
Non-pigmented
1st litter 90 11.1 5.6 1 0.56
2nd litter 21 23.8 4.8 0 0.24
Total 4 1.61
aAmong the control animals no animal had both outcomes. Based on the incidence
rates, 0.14 would have been expected.602 A.H. WALKER et al.
imbalance caused in Sertoli cells and to disruption of sperma-
togenesis due to its effect on the Leydig cells (Yasuda et al.,
1986a).
Studies with mice susceptible to teratomas (129/Sv-ter) have
found that strains with low numbers of primordial germ cells
and a prolonged proliferative period have the highest incidence
of teratoma formation (Noguchi & Stevens, 1982). It appears
that germ cells are most susceptible to teratocarcinogenesis
while in their highest proliferative period.
In summary, thisexperimenthasdemonstrated thatmaternal
exposure toethinyl oestradiol inthe 129 Sv-SI C Pmouse strain
beforeacriticaltimeperiodduringgestationcanaffecttesticular
descent and may affect the incidence of testicular teratomas.
Each ofthese eventsmaybeassociated with oestrogen exposure
through different aetiological mechanisms. Further studies
using this mouse model are necessary to determine if other
maternal hormonal factors can affect the incidence of these
outcomes and to understand the biological mechanisms related
to them.
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